This inventor holds 1 USPTO granted patent. Top assignee: Biosource Technologies, Inc.. Active years: 1999.
Company Filing History:
Years Active: 1999
Title: **Damon Alan Harvey: Innovator in Cytoplasmic Inhibition of Gene Expression**
Introduction
Damon Alan Harvey, an inventive mind based in Vacaville, CA, has made significant contributions to the field of genetic engineering. With one patent to his name, he focuses on novel approaches to gene expression manipulation, aiming to enhance cellular functions in various organisms.
Latest Patents
Harvey's patent, titled "Cytoplasmic Inhibition of Gene Expression," introduces innovative genetic constructions designed for the expression of inhibitory RNA within the cytoplasm of eukaryotic cells. This invention utilizes anti-sense RNA or co-suppressor RNA to decrease the expression of targeted genes, offering potential applications in agriculture and medicine. The technology allows for replication within the cytoplasm of different eukaryotic cells, including plant cells, yeast, and mammalian cells. Notably, when applied to plant cells, Harvey's constructions can be derived from plant RNA viruses, employing subgenomic promoters effective in enhancing carotenoid production, particularly phytoene.
Career Highlights
Harvey is affiliated with Biosource Technologies, Inc., a company known for its innovative biotechnological solutions. His work showcases a blend of genetic engineering and molecular biology, focusing on advancements that could lead to improved agricultural yield and pest resistance.
Collaborations
Throughout his career, Damon has collaborated with esteemed colleagues, including Monto H Kumagai and Guy Richard della-Cioppa. These partnerships reflect a synergy of intellectual expertise that has fortified their collective contributions to the field of genetics and biotechnology.
Conclusion
Damon Alan Harvey exemplifies the spirit of innovation through his groundbreaking work in gene expression control. His patent on cytoplasmic inhibition not only emphasizes his technical proficiency but also paves the way for future advancements in various biological applications. With ongoing collaborations and a commitment to biotechnological innovation, Harvey continues to leave an enduring impact on the scientific community.